Sword Bio and Alturas Analytics Partner on Bioanalytical Services

Sword Bio and Alturas Analytics have entered into a strategic partnership to combine their respective bioanalytical capabilities. The collaboration aims to streamline services for biotechnology and pharmaceutical companies by offering a unified approach to both small- and large-molecule drug development.

Based in Moscow, Idaho, the two firms intend to leverage their complementary technical expertise to manage complex analytical requirements during the drug discovery and development phases. By aligning their laboratory resources, the companies aim to reduce the fragmentation typically associated with outsourcing different stages of bioanalysis.

The agreement is part of a broader industry shift toward integrated contract research models, where clients seek singular platforms for multi-faceted testing requirements. Both companies operate as specialized providers in the preclinical and clinical testing sectors.